{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:43:02Z","timestamp":1769755382447,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12308-024-00599-2","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T09:12:43Z","timestamp":1722589963000},"page":"191-199","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Quantification of the median fluorescence intensity of CD3 and CD4 in mycosis fungoides\/Sezary syndrome versus non-neoplastic control cases in peripheral blood"],"prefix":"10.1007","volume":"17","author":[{"given":"Fei","family":"Fei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nivaz","family":"Brar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa Beth","family":"Herring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua R.","family":"Menke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Oak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0428-0199","authenticated-orcid":false,"given":"Sebastian","family":"Fernandez-Pol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"issue":"2","key":"599_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/cyto.b.21933","volume":"100","author":"KA Lyapichev","year":"2021","unstructured":"Lyapichev KA, Bah I, Huen A, Duvic M, Routbort MJ, Wang W et al (2021) Determination of immunophenotypic aberrancies provides better assessment of peripheral blood involvement by mycosis fungoides\/Sezary syndrome than quantification of CD26- or CD7- CD4+ T-cells. Cytometry B Clin Cytom 100(2):183\u2013191","journal-title":"Cytometry B Clin Cytom"},{"issue":"2","key":"599_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/cyto.b.21888","volume":"100","author":"MP Pulitzer","year":"2021","unstructured":"Pulitzer MP, Horna P, Almeida J (2021) Sezary syndrome and mycosis fungoides: an overview, including the role of immunophenotyping. Cytometry B Clin Cytom 100(2):132\u2013138","journal-title":"Cytometry B Clin Cytom"},{"key":"599_CR3","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SHCE Swerdlow","year":"2017","unstructured":"Swerdlow SHCE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Arber DA, Hasserjian RP, Le Beau MM, Orazi A, Siebert R (2017) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, France"},{"issue":"6","key":"599_CR4","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"E Olsen","year":"2007","unstructured":"Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R et al (2007) Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110(6):1713\u20131722","journal-title":"Blood"},{"issue":"18","key":"599_CR5","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","volume":"29","author":"EA Olsen","year":"2011","unstructured":"Olsen EA, Whittaker S, Kim YH, Duvic M, Prince HM, Lessin SR et al (2011) Clinical end points and response criteria in mycosis fungoides and Sezary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol 29(18):2598\u20132607","journal-title":"J Clin Oncol"},{"issue":"5","key":"599_CR6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/jclinpath-2013-201748","volume":"67","author":"P Horna","year":"2014","unstructured":"Horna P, Deaver DM, Qin D, Moscinski LC, Sotomayor EM, Glass LF et al (2014) Quantitative flow cytometric identification of aberrant T cell clusters in erythrodermic cutaneous T cell lymphoma. Implications for staging and prognosis. J Clin Pathol. 67(5):431\u20136","journal-title":"J Clin Pathol."},{"issue":"2","key":"599_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/cyto.b.21878","volume":"100","author":"P Horna","year":"2021","unstructured":"Horna P, Wang SA, Wolniak KL, Psarra K, Almeida J, Illingworth AJ et al (2021) Flow cytometric evaluation of peripheral blood for suspected Sezary syndrome or mycosis fungoides: international guidelines for assay characteristics. Cytometry B Clin Cytom 100(2):142\u2013155","journal-title":"Cytometry B Clin Cytom"},{"issue":"3","key":"599_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/cyto.b.22070","volume":"102","author":"NE Lewis","year":"2022","unstructured":"Lewis NE, Gao Q, Petrova-Drus K, Pulitzer M, Sigler A, Baik J et al (2022) PD-1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides\/Sezary syndrome. Cytometry B Clin Cytom 102(3):189\u2013198","journal-title":"Cytometry B Clin Cytom"},{"key":"599_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejca.2018.01.076","volume":"93","author":"JJ Scarisbrick","year":"2018","unstructured":"Scarisbrick JJ, Hodak E, Bagot M, Stranzenbach R, Stadler R, Ortiz-Romero PL et al (2018) Blood classification and blood response criteria in mycosis fungoides and Sezary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force. Eur J Cancer 93:47\u201356","journal-title":"Eur J Cancer"},{"issue":"3","key":"599_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/ajcp\/aqac045","volume":"158","author":"F Fei","year":"2022","unstructured":"Fei F, Natkunam Y, Zehnder JL, Stehr H, Gratzinger D (2022) Diagnostic impact of next-generation sequencing panels for lymphoproliferative neoplasms on small-volume biopsies. Am J Clin Pathol 158(3):345\u2013361","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"599_CR11","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jid.2020.09.011","volume":"141","author":"P Horna","year":"2021","unstructured":"Horna P, Shi M, Jevremovic D, Craig FE, Comfere NI, Olteanu H (2021) Utility of TRBC1 expression in the diagnosis of peripheral blood involvement by cutaneous T-cell lymphoma. J Invest Dermatol 141(4):821\u20139 e2","journal-title":"J Invest Dermatol"},{"issue":"1","key":"599_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/cyto.b.21782","volume":"98","author":"M Shi","year":"2020","unstructured":"Shi M, Jevremovic D, Otteson GE, Timm MM, Olteanu H, Horna P (2020) Single Antibody Detection of T-cell receptor alphabeta clonality by flow cytometry rapidly identifies mature T-cell neoplasms and monotypic small CD8-positive subsets of uncertain significance. Cytometry B Clin Cytom 98(1):99\u2013107","journal-title":"Cytometry B Clin Cytom"},{"issue":"4","key":"599_CR13","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.3390\/ijms22041817","volume":"22","author":"P Horna","year":"2021","unstructured":"Horna P, Shi M, Olteanu H, Johansson U (2021) Emerging role of T-cell receptor constant \u03b2 chain-1 (TRBC1) expression in the flow cytometric diagnosis of T-cell malignancies. Int J Mol Sci 22(4):1817","journal-title":"Int J Mol Sci"},{"issue":"3","key":"599_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/cyto.b.21881","volume":"100","author":"H Berg","year":"2021","unstructured":"Berg H, Otteson GE, Corley H, Shi M, Horna P, Jevremovic D et al (2021) Flow cytometric evaluation of TRBC1 expression in tissue specimens and body fluids is a novel and specific method for assessment of T-cell clonality and diagnosis of T-cell neoplasms. Cytometry B Clin Cytom 100(3):361\u2013369","journal-title":"Cytometry B Clin Cytom"},{"issue":"17","key":"599_CR15","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.3390\/cancers13174379","volume":"13","author":"N Mu\u00f1oz-Garc\u00eda","year":"2021","unstructured":"Mu\u00f1oz-Garc\u00eda N, Lima M, Villamor N, Mor\u00e1n-Plata FJ, Barrena S, Mateos S, Caldas C, Balanzategui A, Alcoceba M, Dom\u00ednguez A, G\u00f3mez F (2021) Anti-TRBC1 antibody-based flow cytometric detection of T-cell clonality: standardization of sample preparation and diagnostic implementation. Cancers 13(17):4379","journal-title":"Cancers"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-024-00599-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-024-00599-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-024-00599-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T18:08:10Z","timestamp":1764266890000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-024-00599-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1007\/s12308-024-00599-2","relation":{},"ISSN":["1868-9256","1865-5785"],"issn-type":[{"value":"1868-9256","type":"print"},{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]},"assertion":[{"value":"5 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this type of study, formal consent is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study has obtained IRB approval and the need for informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"For this type of study, consent for publication is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}